[go: up one dir, main page]

FI117000B - Terfenadiinia ja ibuprofeenia sisältävän stabiilin farmaseuttisen koostumuksen valmistusmenetelmä - Google Patents

Terfenadiinia ja ibuprofeenia sisältävän stabiilin farmaseuttisen koostumuksen valmistusmenetelmä Download PDF

Info

Publication number
FI117000B
FI117000B FI961756A FI961756A FI117000B FI 117000 B FI117000 B FI 117000B FI 961756 A FI961756 A FI 961756A FI 961756 A FI961756 A FI 961756A FI 117000 B FI117000 B FI 117000B
Authority
FI
Finland
Prior art keywords
terfenadine
acid
ibuprofen
terfenadone
acids
Prior art date
Application number
FI961756A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI961756A0 (fi
FI961756L (fi
Inventor
Keith David Ertel
David Francis Long
Original Assignee
Aventis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Inc filed Critical Aventis Inc
Publication of FI961756A0 publication Critical patent/FI961756A0/fi
Publication of FI961756L publication Critical patent/FI961756L/fi
Application granted granted Critical
Publication of FI117000B publication Critical patent/FI117000B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
FI961756A 1993-10-25 1996-04-24 Terfenadiinia ja ibuprofeenia sisältävän stabiilin farmaseuttisen koostumuksen valmistusmenetelmä FI117000B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14252893A 1993-10-25 1993-10-25
US14252893 1993-10-25
US9410972 1994-09-28
PCT/US1994/010972 WO1995011677A1 (en) 1993-10-25 1994-09-28 A stable pharmaceutical composition of terfenadine and ibuprofen

Publications (3)

Publication Number Publication Date
FI961756A0 FI961756A0 (fi) 1996-04-24
FI961756L FI961756L (fi) 1996-04-24
FI117000B true FI117000B (fi) 2006-05-15

Family

ID=22500192

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961756A FI117000B (fi) 1993-10-25 1996-04-24 Terfenadiinia ja ibuprofeenia sisältävän stabiilin farmaseuttisen koostumuksen valmistusmenetelmä

Country Status (18)

Country Link
US (1) US5691352A (zh)
EP (1) EP0725639B1 (zh)
JP (1) JPH09509138A (zh)
KR (1) KR100338877B1 (zh)
CN (1) CN1060040C (zh)
AT (1) ATE197544T1 (zh)
AU (1) AU683093B2 (zh)
CA (1) CA2173467A1 (zh)
DE (1) DE69426306T2 (zh)
DK (1) DK0725639T3 (zh)
ES (1) ES2153863T3 (zh)
FI (1) FI117000B (zh)
GR (1) GR3035384T3 (zh)
HU (1) HU222887B1 (zh)
NO (1) NO308773B1 (zh)
NZ (1) NZ274423A (zh)
PT (1) PT725639E (zh)
WO (1) WO1995011677A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2134743B1 (es) * 1998-02-06 2000-05-01 Biocosmetics Sl Composicion para el tratamiento de la halitosis.
US5962488A (en) 1998-04-08 1999-10-05 Roberts Laboratories, Inc. Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives
TWI313598B (en) * 2002-12-18 2009-08-21 Wyeth Corp Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
CN101417131B (zh) * 2007-10-22 2010-11-10 鲁南制药集团股份有限公司 一种用于治疗皮肤过敏性疾病的外用药物组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4285957A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4999226A (en) * 1988-06-01 1991-03-12 Merrell Dow Pharmaceuticals Inc. Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
JPH06502166A (ja) * 1990-09-28 1994-03-10 メルク　エンド　カンパニー　インコーポレーテッド イブプロフェン−抗ヒスタミン薬の組み合わせ
US5512300A (en) * 1992-09-15 1996-04-30 Warner-Lambert Company Prevention of ibuprofen from forming low melting eutectics with other therapeutic agents in solid dosage forms

Also Published As

Publication number Publication date
FI961756A0 (fi) 1996-04-24
HUT74577A (en) 1997-01-28
AU683093B2 (en) 1997-10-30
AU7845694A (en) 1995-05-22
FI961756L (fi) 1996-04-24
CN1133560A (zh) 1996-10-16
ATE197544T1 (de) 2000-12-15
EP0725639A1 (en) 1996-08-14
US5691352A (en) 1997-11-25
CN1060040C (zh) 2001-01-03
NZ274423A (en) 1997-10-24
HU222887B1 (hu) 2003-12-29
NO308773B1 (no) 2000-10-30
HU9601074D0 (en) 1996-06-28
KR100338877B1 (ko) 2002-12-05
DK0725639T3 (da) 2000-12-11
ES2153863T3 (es) 2001-03-16
WO1995011677A1 (en) 1995-05-04
EP0725639B1 (en) 2000-11-15
KR960705565A (ko) 1996-11-08
PT725639E (pt) 2001-02-28
JPH09509138A (ja) 1997-09-16
CA2173467A1 (en) 1995-05-04
NO961640D0 (no) 1996-04-24
NO961640L (no) 1996-04-24
DE69426306D1 (de) 2000-12-21
GR3035384T3 (en) 2001-05-31
DE69426306T2 (de) 2001-06-07

Similar Documents

Publication Publication Date Title
CN103826633B (zh) 哌甲酯前药、其制备和使用方法
Kommuru et al. Racemate and enantiomers of ketoprofen: phase diagram, thermodynamic studies, skin permeability, and use of chiral permeation enhancers
JPH03849B2 (zh)
EP0264887A1 (en) Drug compositions stabilized against oxidation and discoloration
JP2023113803A (ja) シチシンのコハク酸塩およびその使用
FI117000B (fi) Terfenadiinia ja ibuprofeenia sisältävän stabiilin farmaseuttisen koostumuksen valmistusmenetelmä
KR100440354B1 (ko) 티아가빈염산염함유약학적조성물및그제조방법
WO1998003202A1 (en) Sorbefacients
AU736539B2 (en) Method for producing stable acetylsalicylic acid solutions
DE2416491C3 (de) 13.02.74 V.SLVAmerika 442033 Dibenzopyranverbindungen und diese enthaltende Arzneimittel Abbott Laboratories, North Chicago, 111. (V.StA.)
JPH0421670A (ja) 光学活性インダノン誘導体
JPWO1993005778A1 (ja) 血中脂質代謝改善剤
US20060229277A1 (en) Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor
JPS585167B2 (ja) 麦角アルカロイド類の安定な医薬組成物
WO1993005778A1 (fr) Agent ameliorant le metabolisme lipidique du sang
Przybył et al. Molecular structure and spectroscopic studies of (−)-cytisine salt with (+)-tartaric acid
WO2008069469A1 (en) Crystalline s-(-)-amlodipine camsylate anhydride and preparation method thereof
WO2008054096A1 (en) Crystalline s-(-)-amlodipine adipic acid salt anhydrous and preparation method thereof
Thakral et al. Reduction in moisture sensitivity/uptake of moisture sensitive drugs through adduction in urea
FI105919B (fi) Menetelmä (+)-5-bentsoyyli-2,3-dihydro-1H-pyrrolitsiini-1-karboksyylihapon 2-(1-pyrrolidinyyli)etyyliesterin farmaseuttisesti hyväksyttävien happoadditiosuolojen valmistamiseksi
US3773944A (en) Method of treating hyperchlorhydria and/or associated conditions
CN1233372C (zh) 治疗心脑血管疾病含银杏叶提取物的口服复方药物制剂
KR100765464B1 (ko) 암로디핀 말레이트를 포함하는 약제조성물 및 그 제조 방법
AU2005216862A1 (en) Compositions comprising prodrugs of proton pump inhibitors
AU2004279378A1 (en) Methods and compositions for the oral administration of prodrugs of proton pump inhibitors

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: AVENTIS INC.

Free format text: AVENTIS INC.

FG Patent granted

Ref document number: 117000

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: AVENTISUB II INC.

Free format text: AVENTISUB II INC.

MA Patent expired